牛牛AI助手已提取核心信息
On February 22, 2024, Cingulate Inc., a company listed on The Nasdaq Capital Market, announced that it had regained compliance with Nasdaq's board composition requirements following the appointment of three independent board members on February 12, 2024. Additionally, the Nasdaq Hearings Panel granted Cingulate an exception to continue meeting the minimum stockholders' equity requirement of $2.5 million through May 13, 2024. This decision comes after a series of compliance challenges for Cingulate, which began with a notice from Nasdaq on May 16, 2023, regarding the company's failure to meet the Minimum Stockholders' Equity Rule. Cingulate submitted a compliance plan on June 30, 2023, and received an extension until November 13, 2023. However, on November 14, 2023, Nasdaq determined to delist the company's securities due to non-compliance, prompting Cingulate to request a...Show More
On February 22, 2024, Cingulate Inc., a company listed on The Nasdaq Capital Market, announced that it had regained compliance with Nasdaq's board composition requirements following the appointment of three independent board members on February 12, 2024. Additionally, the Nasdaq Hearings Panel granted Cingulate an exception to continue meeting the minimum stockholders' equity requirement of $2.5 million through May 13, 2024. This decision comes after a series of compliance challenges for Cingulate, which began with a notice from Nasdaq on May 16, 2023, regarding the company's failure to meet the Minimum Stockholders' Equity Rule. Cingulate submitted a compliance plan on June 30, 2023, and received an extension until November 13, 2023. However, on November 14, 2023, Nasdaq determined to delist the company's securities due to non-compliance, prompting Cingulate to request a hearing. The company also faced issues with board member resignations in December 2023, which further violated Nasdaq's independent director and committee requirements. Despite these setbacks, Cingulate successfully regained compliance with the minimum closing bid price requirement following a reverse stock split on November 30, 2023. The company acknowledges that there is no assurance of maintaining long-term compliance with Nasdaq's requirements or avoiding delisting, which could significantly impact its business and stock liquidity.
2024年2月22日，在纳斯达克资本市场上市的公司Cingulate Inc. 宣布，在2024年2月12日任命了三名独立董事会成员后，它已恢复遵守纳斯达克的董事会组成要求。此外，纳斯达克听证会小组批准了Cingulate的例外情况，即在2024年5月13日之前继续满足250万美元的最低股东权益要求。该决定是在Cingulate面临一系列合规挑战之后做出的，这首先是纳斯达克于2023年5月16日发布的关于该公司未能满足最低股东权益规则的通知。Cingulate 于 2023 年 6 月 30 日提交了合规计划，并获准延期至 2023 年 11 月 13 日。但是，2023年11月14日，纳斯达...展开全部
2024年2月22日，在纳斯达克资本市场上市的公司Cingulate Inc. 宣布，在2024年2月12日任命了三名独立董事会成员后，它已恢复遵守纳斯达克的董事会组成要求。此外，纳斯达克听证会小组批准了Cingulate的例外情况，即在2024年5月13日之前继续满足250万美元的最低股东权益要求。该决定是在Cingulate面临一系列合规挑战之后做出的，这首先是纳斯达克于2023年5月16日发布的关于该公司未能满足最低股东权益规则的通知。Cingulate 于 2023 年 6 月 30 日提交了合规计划，并获准延期至 2023 年 11 月 13 日。但是，2023年11月14日，纳斯达克因违规决定将该公司的证券退市，这促使Cingulate要求举行听证会。该公司还面临2023年12月董事会成员辞职的问题，这进一步违反了纳斯达克的独立董事和委员会的要求。尽管遇到了这些挫折，但在2023年11月30日股票反向拆分后，Cingulate成功恢复了对最低收盘价要求的遵守。该公司承认，无法保证长期遵守纳斯达克的要求或避免退市，这可能会严重影响其业务和股票流动性。
有用
没用